|
|
|
|
Advances in Assisted Reproductive Technologies (ART)
Biocoat, Inc. develops biomedical applications based on hyaluronic acid and its technology is being put to use in the field of human reproduction.
Biocoat and its U.S. distributor, Mid-Atlantic Diagnostics, have commercialized two unique products for the diagnosis and treatment of male infertility that are changing the way sperm testing is done and ICSI in vitro fertilization procedures are performed in leading IVF clinics around the world.
HBA®
The HBA Sperm-Hyaluronan Binding Assay indicates relative sperm maturity and helps urologists, embryologists and fertility clinics diagnose male infertility and select proper treatment.
PICSI®
The PICSI Sperm Selection Device can improve the effectiveness of ICSI (IntraCytoplasmic Sperm Injection) when the male parent has a low HBA score by selecting the mature sperm and avoiding the immature ones.
Facts:
One in six couples worldwide experience some form of
Infertility
In 40% of the cases the problem is due to the male
|
Testimonials:
The "Conceive This" Blog
|
|
|
|
|
|
|